Purdue University scientists developed a new treatment option for lung fibrosis. Lung fibrosis has been an important concern for COVID-19 patients.

‘New targeted therapies allow to use powerful drugs that specifically deliver them to diseased cells without harming healthy ones.’
Read More..

"This is a horrible disease that claimed the lives of my next-door neighbor and a good friend's wife," Low said. "We developed two targeted therapies that allow us to use powerful drugs with high toxicities because we specifically deliver them to diseased cells without harming healthy ones."Read More..





The first therapy is designed to slow fibrosis and improve survival rate. The second one is to suppresses fibrosis-inducing cytokine production.
These therapies will be moving into human clinical trials soon, as many patients with COVID-19 or who have recovered from COVID-19 experience lung fibrosis or related conditions.
Source-Medindia